Hemoglobin A1c and short-term outcomes in patients with acute myocardial infarction undergoing primary angioplasty: An observational multicenter study

Coronary Artery Disease

Volumn 24, Issue 1, 2013, Pages 16-22

  Tian, Li ^a   Zhu, Jun ^a   Liu, Lisheng ^a   Liang, Yan ^a   Li, Jiandong ^a   Yang, Yanmin ^a  

^a National Center for Cardiovascular Diseases   (China)

Author keywords

blood glucose; hemoglobin A1c; percutaneous transluminal coronary angioplasty; ST segment elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CHINA; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITAL MORTALITY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PATIENT READMISSION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871808351     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32835b3971     Document Type: Article

References (24)

1. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol 1995; 25:370-377.
2. De Mulder M, Cornel JH, van der Ploeg T, Boersma E, Umans VA. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy. Am Heart J 2010; 160:412-419.
3. Naber CK, Mehta RH, Ju? nger C, Zeymer U,Wienbergen H, Sabin GV, et al. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry). Am J Cardiol 2009; 103:583-587.
4. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med 2004; 21:657-665.
5. Standards of medical care in diabetes - 2010. Diabetes Care 2010; 33 (Suppl 1):S11-S61.
6. Cicek G, Uyarel H, Ergelen M, Ayhan E, Abanonu GB, Eren M, Gibson CM. Hemoglobin A1c as a prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis 2011; 22: 131-137.
7. Chan CY, Li R, Chan JY, Zhang Q, Chan CP, Dong M, et al. The value of admission HbA(1c) level in diabetic patients with acute coronary syndrome. Clin Cardiol 2011; 34:507-512.
8. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76:142-154.
9. Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010; 123 (Suppl):S3-S11.
10. Selvin E, Steffes MW, Zhu H, Matsushita K,Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 2010; 362:800-811.
11. Cakmak M, Cakmak N, Cetemen S, Tanriverdi H, Enc Y, Teskin O, Kilic ID. The value of admission glycosylated hemoglobin level in patients with acute myocardial infarction. Can J Cardiol 2008; 24:375-378.
12. Tenerz A, Nilsson G, Forberg R, Ohrvik J, Malmberg K, Berne C, Leppert J. Basal glucometabolic status has an impact on long-term prognosis following an acute myocardial infarction in non-diabetic patients. J Intern Med 2003; 254:494-503.
13. Halkos ME, Lattouf OM, Puskas JD, Kilgo P, Cooper WA, Morris CD, et al. Elevated preoperative hemoglobin A1c level is associated with reduced long-term survival after coronary artery bypass surgery. Ann Thorac Surg 2008; 86:1431-1437.
14. Gustafsson I, Kistorp CN, James MK, Faber JO, Dickstein K, Hildebrandt PR. Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction. Am Heart J 2007; 154:470-476.
15. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment-elevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124:704-711.
16. Hadjadj S, Coisne D, Mauco G, Ragot S, Duengler F, Sosner P, et al. Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med 2004; 21:305-310.
17. Cao JJ, Hudson M, Jankowski M, Whitehouse F, Weaver WD. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005; 96:183-186.
18. Britton KA, Aggarwal V, Chen AY, Alexander KP, Amsterdam E, Fraulo E, et al. No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction. Am Heart J 2011; 161:657-663 e1.
19. Kauffman AB, Delate T, Olson KL, Cymbala AA, Hutka KA, Kasten SL, Rasmussen Jr. Relationship between haemoglobin A1C values and recurrent cardiac events: a retrospective, longitudinal cohort study. Clin Drug Investig 2008; 28:501-507.
20. Diaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, et al. Glucose-insulin- potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA 2007; 298:2399-2405.
21. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41:1-7.
22. Diedrichs H, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without type 2 diabetes mellitus. Diabet Med 2008; 25:228-231.
23. Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, et al. Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 2012; 55:636-643.
24. Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011; 364:818-828.